M&A Deal Summary |
|
|---|---|
| Date | 2017-09-22 |
| Target | Inform Diagnostics |
| Sector | Life Science |
| Buyer(s) | Avista Healthcare Partners |
| Sellers(s) | Miraca Holdings |
| Deal Type | Divestiture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 8.0B USD |
| Size | Mega |
| Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 37 of 56 |
| Sector: Life Science M&A | 7 of 13 |
| Type: Divestiture M&A Deals | 5 of 9 |
| State: Texas M&A | 8 of 8 |
| Country: United States M&A | 30 of 44 |
| Year: 2017 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-06-05 |
National Spine & Pain Centers
Frederick, Maryland, United States National Spine & Pain Centers is a provider of interventional pain management services focused on relieving chronic back and neck pain. Interventional pain management is a rapidly growing medical specialty whose objective is to relieve pain through advanced, minimally invasive procedures while preventing costly, invasive surgery. National Spine & Pain Centers provides management services to physicians who are dedicated to providing high quality patient care in outpatient ambulatory surgical center settings. Affiliated physicians are fellowship-trained and board-certified/board-eligible pain specialists and many are nationally recognized leaders in pain management. National Spine & Pain Centers was founded in 1998 and is headquartered in Frederick, Maryland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-10-12 |
OptiNose
Yardley, Pennsylvania, United States OptiNose is a specialty pharmaceutical company focused on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. OptiNose was founded in 2000 and is based in Yardley, Pennsylvania. |
Sell | - |
Miraca Holdings, Inc. is engaged in the business consisting of three segments: (i) development, manufacture, and commercialization of in vitro diagnostics, (ii) clinical laboratory testing, and (iii) other healthcare related businesses.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-11-22 |
Caris Life Sciences - Anatomic Pathology Business
United States
|
Buy | $725M |
